Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survival

Transplant International

Volumn 19, Issue 11, 2006, Pages 893-900

  Helanterä, Ilkka ^a   Koskinen, Petri ^a   Finne, Patrik ^a   Loginov, Raisa ^a   Kyllönen, Lauri ^b   Salmela, Kaija ^b   Grönhagen Riska, Carola ^a   Lautenschlager, Irmeli ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Division of Transplantation   (Finland)

Author keywords

Chronic allograft nephropathy; Chronic graft dysfunction; Cytomegalovirus; Kidney transplantation

Indexed keywords

CREATININE; VIRUS ANTIGEN; VIRUS DNA;

ARTICLE; BLOOD ANALYSIS; CREATININE CLEARANCE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DNA HYBRIDIZATION; FOLLOW UP; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; URINALYSIS;

ADULT; BIOPSY; CYTOMEGALOVIRUS INFECTIONS; DNA; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RISK FACTORS;

EID: 33749431237     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2006.00364.x     Document Type: Article

References (20)

1. Pouteil-Noble C, Ecochard R, Landrivon G, et al. Cytomegalovirus infection - an etiological factor for rejection? A prospective study in 242 renal transplant patients. Transplantation 1993; 55: 851.
2. Sagedal S, Nordal KP, Hartmann A, et al. The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am J Transplant 2002; 2: 850.
3. Almond PS, Matas A, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752.
4. Paul LC. Chronic allograft nephropathy: an update. Kidney Int 1999; 56: 783.
5. Helantera I, Koskinen P, Tornroth T, Loginov R, Gronhagen-Riska C, Lautenschlager I. The impact of cytomegalovirus infections and acute rejection episodes on the development of vascular changes in 6-month protocol biopsy specimens of cadaveric kidney allograft recipients. Transplantation 2003; 75: 1858.
6. Humar A, Gillingham KJ, Payne WD, Dunn DL, Sutherland DE, Matas AJ. Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients. Transplantation 1999; 68: 1879.
7. Dickenmann MJ, Cathomas G, Steiger J, Mihatsch MJ, Thiel G, Tamm M. Cytomegalovirus infection and graft rejection in renal transplantation. Transplantation 2001; 71: 764.
8. Arnold JC, Portmann BC, O'Grady JG, Naoumov NV, Alexander GJ, Williams R. Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome. Hepatology 1992; 16: 285.
9. Lautenschlager I, Hockerstedt K, Jalanko H, et al. Persistent cytomegalovirus in liver allografts with chronic rejection. Hepatology 1997; 25: 190.
10. Holma K, Tornroth T, Gronhagen-Riska C, Lautenschlager I. Expression of the cytomegalovirus genome in kidney allografts during active and latent infection. Transpl Int 2000; 13: S363.
11. Helantera I, Loginov R, Koskinen P, Tornroth T, Gronhagen-Riska C, Lautenschlager I. Persistent cytomegalovirus infection is associated with increased expression of TGF-β1, PDGF-AA and ICAM-1 and arterial intimal thickening in kidney allografts. Nephrol Dial Transplant 2005; 20: 790.
12. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
13. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31.
14. Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 1995; 48: 1503.
15. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996; 49: 1373.
16. Sagedal S, Hartmann A, Nordal KP, et al. Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney Int 2004; 66: 329.
17. Giral M, Nguyen JM, Daguin P, et al. Mycophenolate mofetil does not modify the incidence of cytomegalovirus (CMV) disease after kidney transplantation but prevents CMV-induced chronic graft dysfunction. J Am Soc Nephrol 2001; 12: 1758.
18. Kloover JS, Soots AP, Krogerus LA, et al. Rat cytomegalovirus infection in kidney allograft recipients is associated with increased expression of intracellular adhesion molecule-1 vascular adhesion molecule-1, and their ligands leukocyte function antigen-1 and very late antigen-4 in the graft. Transplantation 2000; 69: 2641.
19. Yilmaz S, Koskinen PK, Kallio E, Bruggeman CA, Hayry PJ, Lemstrom KB. Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression. Kidney Int 1996; 50: 526.
20. Salmela KT, Kyllonen LE. Two decades of experience with cyclosporine in renal transplantation in Helsinki. Transplant Proc 2004; 36: 94S.